Steatosis and insulin resistance in hepatitis C: A way out for the virus?

Del Campo, José A.; Romero-Gómez, Manuel; Méndez-Sánchez, Nahum; Burczynski, Frank J.
October 2009
World Journal of Gastroenterology;10/28/2009, Vol. 15 Issue 40, p5014
Academic Journal
The hepatitis C virus (HCV) induces lipid accumulation in vitro and in vivo. The pathogenesis of steatosis is due to both viral and host factors. Viral steatosis is mostly reported in patients with genotype 3a, whereas metabolic steatosis is often associated with genotype 1 and metabolic syndrome. Several molecular mechanisms responsible for steatosis have been associated with the HCV core protein, which is able to induce gene expression and activity of sterol regulatory element binding protein 1 (SREBP1) and peroxisome proliferator-activated receptor ? (PPAR?), increasing the transcription of genes involved in hepatic fatty acid synthesis. Steatosis has been also implicated in viral replication. In infected cells, HCV core protein is targeted to lipid droplets which serve as intracellular storage organelles. These studies have shown that lipid droplets are essential for virus assembly. Thus, HCV promotes steatosis as an efficient mechanism for stable viral replication. Chronic HCV infection can also induce insulin resistance. In patients with HCV, insulin resistance is more strongly associated with viral load than visceral obesity. HCV seems to lead to insulin resistance through interference of intracellular insulin signalling by HCV proteins, mainly, the serine phosphorylation of insulin receptor-1 (IRS-1) and impairment of the downstream Akt signalling pathway. The HCV core protein interferes with in vitro insulin signalling by genotype-specific mechanisms, where the role of suppressor of cytokine signal 7 (SOCS-7) in genotype 3a and mammalian target of rapamycin (mTOR) in genotype 1 in IRS-1 downregulation play key roles. Steatosis and insulin resistance have been associated with fibrosis progression and a reduced rate of sustained response to peginterferon plus ribavirin.


Related Articles

  • Hepatic steatosis: A benign disease or a silent killer. El-Zayadi, Abdel-Rahman // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4120 

    Steatosis is a common feature of many liver diseases, namely non-alcoholic steatohepatitis (NASH) and hepatitis C virus (HCV) infection, but the pathogenic mechanisms differ. Insulin resistance (IR), a key feature of metabolic syndrome, is crucial for NASH development, associated with many...

  • Insulin Resistance in Patients with Chronic Hepatitis C Infection. Abd El-Satar, Hoda; Mahfouz, Mahmoud; Rashed, Layla; Ahmed, Dalia // Australian Journal of Basic & Applied Sciences;2010, Vol. 4 Issue 10, p4554 

    Chronic HCV infection has emerged as a complex multifaceted disease with manifestations extending beyond the liver. Hepatic steatosis, insulin resistance (IR) and type II diabetes have been observed to occur more frequently in association with HCV infection than other chronic inflammatory liver...

  • Hepatitis C Virus, Oxidative Stress and Steatosis: Current Status and Perspectives. González-Gallego, J.; García-Mediavilla, M. V.; Sánchez-Campos, S. // Current Molecular Medicine;Jul2011, Vol. 11 Issue 5, p373 

    Reactive oxygen and nitrogen species (ROS/RNS), whether produced endogenously as a consequence of normal cell functions or derived from external sources, pose a constant threat to cells living in an aerobic environment. When the production of ROS/RNS overrides the antioxidant capability of the...

  • Insulin resistance and steatosis in hepatitis C virus infection. Zekry, A.; McHutchison, J. G.; Diehl, A. M. // Gut;Jul2005, Vol. 54 Issue 7, p903 

    The article discusses insulin resistance (IR) and steatosis in hepatitis C virus (HCV) infection. Steatosis in patients with genotype 1 infection is increasingly recognized as a component of the metabolic syndrome, a condition invariably associated with IR. In support, host factors such as age,...

  • Hepatitis C Virus Induces the Cannabinoid Receptor 1. van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Tran, Kayla; McLeod, Duncan; Milliken, Jane S.; Ho, Vikki; Hebbard, Lionel W.; Douglas, Mark W.; George, Jacob // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Background: Activation of hepatic CB1 receptors (CB1) is associated with steatosis and fibrosis in experimental forms of liver disease. However, CB1 expression has not been assessed in patients with chronic hepatitis C (CHC), a disease associated with insulin resistance, steatosis and metabolic...

  • The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C. Savvoula, Savvidou; Dimitrios, Chrysagis; George, Papatheodoridis; Spilios, Manolakopoulos; Christos, Triantos; John, Goulis // Gastroenterology Research & Practice;2012, p1 

    Background. Recent data suggest that chronic hepatitis C has to be considered a metabolic disease further to a viral infection. The aim of this study was to elaborate on the complex interactions between hepatitis C virus, host metabolic factors, and treatment response. Methods. Demographic,...

  • CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION. Cristina, Daha Ioana; Ioana, Olaru; Alexandra, Iernici; Ionescu, R. A.; Dan, Gh. A. // Therapeutics, Pharmacology & Clinical Toxicology;Jun2012, Vol. 16 Issue 2, p85 

    Cardiovascular disease and chronic hepatitis C virus (HCV) infection are major public health problems causing significant morbidity and mortality in millions of people worldwide. There is growing evidence that there is an association between HCV infection, cardiovascular disease and metabolic...

  • Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients. Sampaio Péres, Décio Passos; Cheinquer, Hugo; Fernando Herz Wolf, Fernando Herz; Cheinquer, Nelson; Falavigna, Maicon; Sampaio Péres, Luciana Dornelles // Annals of Hepatology: Official Journal of the Mexican Associatio;Nov/Dec2013, Vol. 12 Issue 6, p871 

    Background and rationale. Chronic infection with the hepatitis C virus (HCV) is associated with a higher prevalence of insulin resistance compared to the general population. This finding is associated with hepatic steatosis, increased liver fibrosis and lower rates of sustained virological...

  • Hepatitis C and Metabolic Disorders: Genetics, Mechanism, and Therapies (Clinical and Experimental). Alvares-da-Silva, Mario Reis; Wedemeyer, Heiner; Cortez-Pinto, Helena; Souza de Oliveira, Claudia Pinto Marques // International Journal of Hepatology;2012, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including Hepatitis C virus influence on extrahepatic disease such as insulin resistance, chronic kidney diseases and diabetes mellitus.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics